Last reviewed · How we verify
Use of Chinese Herbal Formula Shu Yu Wan in Lung Cancer Patients: a Randomized Double-blind Placebo- Controlled Trial (CH:II)
The purpose of this study is to evaluate whether Chinese Herb supplements lead to a measurable improvement in symptoms commonly experienced by patients with advanced stage lung cancer and an improvement in quality of life. In our previously conducted single-arm observational study we found significant improvement in physical well-being, tiredness and drowsiness with no evidence of increased toxicity even in those on cytotoxic chemotherapy. Based on the encouraging results of this study we plan to move to a placebo-controlled study using the same Chinese Herb formula.
Details
| Lead sponsor | Lady Davis Institute |
|---|---|
| Phase | NA |
| Status | WITHDRAWN |
| Start date | 2022-03 |
| Completion | 2024-03 |
Conditions
- Metastatic NSCLC
Interventions
- Chinese herbs formula: Shu Yu Wan
- Placebo capsules
Primary outcomes
- Physical Well-Being Scores at Baseline and 6 Weeks — Baseline and 6 weeks
The primary objective is to compare the change in patient reported Physical Well-Being (PWB) subscale of the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire. The Physical well-being (PWB) subscale has 7 questions with the range of the score from 0 to 4 each. The range of the total score is 0 to 28. The higher the score the better the physical well-being.
Countries
Canada